Tezepelumab effectiveness in Aspirin-Exacerbated Respiratory Disease: a real-world multicenter study.

Betancor D, Villalobos-Violan V, Antolin-Amerigo D, De Las Vecillas L, Cárdenas-Contreras R, Elices A, Gandolfo-Cano M, Lopez-Gonzalez P, Moro-Moro M, Núñez-Acevedo B, Pineda R, Reaño M, Robledo-Echarren T, Rosado-Ingelmo A, Gutierrez-Albaladejo N, Rubio-Perez M, Valverde-Monge M, Vazquez de la Torre M, Feliu-Vila A, Gabriela LZ, Martín-Arriscado C, Garcia-Moguel I, Dominguez-Ortega J, AIRE Group

Open source

DOI
10.1016/j.rmed.2026.109178
Published
2026 Sep 23
Container
Respiratory medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2026.109178,
  title = {Tezepelumab effectiveness in Aspirin-Exacerbated Respiratory Disease: a real-world multicenter study.},
  author = {Betancor D and Villalobos-Violan V and Antolin-Amerigo D and De Las Vecillas L and Cárdenas-Contreras R and Elices A and Gandolfo-Cano M and Lopez-Gonzalez P and Moro-Moro M and Núñez-Acevedo B and Pineda R and Reaño M and Robledo-Echarren T and Rosado-Ingelmo A and Gutierrez-Albaladejo N and Rubio-Perez M and Valverde-Monge M and Vazquez de la Torre M and Feliu-Vila A and Gabriela LZ and Martín-Arriscado C and Garcia-Moguel I and Dominguez-Ortega J and AIRE Group},
  year = {2026},
  journal = {Respiratory medicine},
  doi = {10.1016/j.rmed.2026.109178},
  url = {https://doi.org/10.1016/j.rmed.2026.109178}
}

RIS

TY  - JOUR
TI  - Tezepelumab effectiveness in Aspirin-Exacerbated Respiratory Disease: a real-world multicenter study.
AU  - Betancor D
AU  - Villalobos-Violan V
AU  - Antolin-Amerigo D
AU  - De Las Vecillas L
AU  - Cárdenas-Contreras R
AU  - Elices A
AU  - Gandolfo-Cano M
AU  - Lopez-Gonzalez P
AU  - Moro-Moro M
AU  - Núñez-Acevedo B
AU  - Pineda R
AU  - Reaño M
AU  - Robledo-Echarren T
AU  - Rosado-Ingelmo A
AU  - Gutierrez-Albaladejo N
AU  - Rubio-Perez M
AU  - Valverde-Monge M
AU  - Vazquez de la Torre M
AU  - Feliu-Vila A
AU  - Gabriela LZ
AU  - Martín-Arriscado C
AU  - Garcia-Moguel I
AU  - Dominguez-Ortega J
AU  - AIRE Group
PY  - 2026
JO  - Respiratory medicine
DO  - 10.1016/j.rmed.2026.109178
UR  - https://doi.org/10.1016/j.rmed.2026.109178
ER  - 

APA

D, B., V, V., D, A., L, D. L. V., R, C., A, E., M, G., P, L., M, M., B, N., R, P., M, R., T, R., A, R., N, G., M, R., M, V., M, V. D. L. T., A, F., LZ, G., C, M., I, G., J, D., & Group, A. (2026). Tezepelumab effectiveness in Aspirin-Exacerbated Respiratory Disease: a real-world multicenter study.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2026.109178

Source records